Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma

NCT01181895 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

348

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Vilanterol
DRUG: Salmeterol Inhalation Powder
DRUG: Placebo Inhalation Powder NDPI
DRUG: Placebo Inhalation Powder Diskus

Sponsor

GlaxoSmithKline